Bacillus Calmette–Guérin (BCG) immunotherapy for bladder cancer has been used since
1976 when the first evidence of its ability to lower recurrence and progression rates was …

Objective Mycotic aortic aneurysm is a rare and life-threatening pathology. The first case of
mycotic aneurysm induced by immunotherapy with bacille Calmette-Guérin for malignancy …

Background So called “mycotic” aortic aneurysms account for only 0.7 to 1.3% of all aortic
aneurysms and are commonly caused by Staphylococcus aureus and Salmonella species …

An abdominal aortic aneurysm (AAA) is a multifactorial disease with a variety of genetic and
environmental risk factors, but the exact mechanism of AAA formation and progression is still …

(1) Background: Intravesical instillation of therapeutic Bacillus Calmette-Guerin (BCG) is the
standard of treatment for non-muscular invasive bladder cancer. Although the exact …

Abstract Bacillus Calmette-Guérin (BCG) vaccine has been successfully used to treat
bladder cancer. However, sporadic cases of mycotic arterial aneurysms have been reported …

Background/Aim: As the population ages, there are increasing findings of coincidental
diseases such as abdominal aortic aneurysm (AAA) and intra-abdominal, retroperitoneal …

Objective This study aimed to determine the therapeutic effectiveness of tuberculous aortic
aneurysms (TBAAs) and the risk factors for mortality. Methods We reviewed all case reports …

Abstract Intravesical instillation of Bacillus Calmette-Guerin, a live-attenuated strain of
Mycobacterium bovis, is a common adjuvant therapy for bladder cancer with a low incidence …

A mycotic aneurysm after intravesical instillation of bacillus Calmette-Guérin (BCG) for early-
stage bladder cancer is a rare, but life-threatening, complication. In the present report, we …